Dr. Mauricio Ricardo Monrroy Prado, MD

Dr. Monrroy Prado practices at Albany Medical Center / South Clinical Campus in Albany, New York.

Dr. Monrroy Prado's NPI, 1285836353, was assigned on June 1, 2007. Dr. Monrroy Prado holds Virginia license 0101251095.

Dr. Monrroy Prado's primary practice is Albany Medical Center / South Clinical Campus, at 25 Hackett Blvd, Albany, NY 12208 in Albany County. The practice phone is (866) 262-7476.

Dr. Monrroy Prado's primary practice is Albany Medical Center / South Clinical Campus in Albany, New York. Dr. Monrroy Prado is also affiliated with Albany Medical Center. The medical group on file is Albany Med EmUrgentCare. Dmand AI also links Dr. Monrroy Prado to 4 more hospitals and 3 dialysis centers, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Monrroy Prado practices, 8 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Monrroy Prado's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Monrroy Prado is licensed in Virginia.

CMS data shows 1,032 Medicare services from Dr. Monrroy Prado across 10 procedure codes in 2024, for 358 Medicare patients. Medicare paid $83,856 for them.

CMS counts 358 Medicare patients who saw Dr. Monrroy Prado in 2024. The largest group is 75 to 84, with 122 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 30% are also on Medicaid. Their average risk score is 4.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Monrroy Prado's median patient age at 68, with 45% women.

In 2024, Dr. Monrroy Prado wrote 1,495 Medicare Part D claims for 201 patients. 82% of them were for generic drugs. CMS names the drug for 1,250 of them, across 33 drugs with 11 or more claims each, at $191,856 in total drug cost. In 2023, CMS named 1,144 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Monrroy Prado for performance year 2024, reported as part of a group. Dr. Monrroy Prado accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Monrroy Prado as offering telehealth.

CMS Open Payments shows 2 general payments to Dr. Monrroy Prado from 2 drug and device companies from 2019 to 2024. Honoraria make up the largest share, 83% of the total. Alexion Pharmaceuticals, Inc. paid the most, $150.